We did a pooled analysis of three randomised controlled trials done in Nepal (2011-2014), Mali (2011-2014), and South Africa (2011-2013). We aimed to determine the vaccine efficacy of maternal influenza immunisation against maternal and infant PCR-confirmed influenza, duration of protection, and the effect of gestational age at vaccination on vaccine efficacy, birth outcomes, and infant growth up to 6 months of age. Maternal influenza immunisation can reduce morbidity and mortality associated with influenza infection in pregnant women and young infants. 10 Bill & Melinda Gates Foundation, Seattle, WA, USA Vaccines For All, Pune, India.9 Cincinnati Children's Hospital Global Health Center, Cincinnati, OH, USA.8 Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.7 Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.6 Department of Health, Behavior, Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.5 Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa Section of Infectious Diseases, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA Department of Epidemiology, Center for Global Health Colorado School of Public Health, Aurora, CO, USA.4 Centre pour le Développement des Vaccins, Bamako, Mali Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA. ![]() 3 Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa Department of Science and Technology/National Research Foundation, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.Electronic address: 2 Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA. 1 Yale Institute for Global Health, New Haven, CT, USA Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA Yale School of Nursing, New Haven, CT, USA Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.This is an ideal resource for all clinicians administering vaccines and their healthcare teams. This book aims to improve the efficiency and effectiveness of clinical vaccine discussions with patients, leading to more informed patients and timely vaccination. There are also sections outlining the vaccine safety system and evidence-based strategies for how to talk with patients about vaccines. The organization of the information makes it easy to reference specific topics and quickly find pertinent information, with the most practical details (such as recommendations and causality conclusions) highlighted at the very beginning of the respective sections. Each topic, from specific vaccines to safety concerns, is covered succinctly, based upon systematic reviews of the scientific literature, with talking points to be used with patients. This book provides clinicians and their staff with essential information on the vaccines that are recommended and not recommended for their patients, the diseases these vaccines prevent, and a broad range of potential vaccine safety issues that may be brought up by their patients.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |